I am thrilled to compose this July 2016 edition of Oviya MedSafe’s newsletter which intends to spotlight our achievements during the month, with a note of emphasis on how we comprehend the purpose of our journey in pharmacovigilance across times.
Being a doctor (physician) in India, every July has been important to me, as July 1st has always been celebrated as Doctors Day in the country. But, the Doctors Day of 2016 proved to be the first one that came really close to my heart, thanks to the Coimbatore Branch of the Indian Medical Association (IMA) which honoured me with the ‘Leadership Excellence Award‘, in appreciation of my leadership as a Business Leader spearheading Oviya MedSafe as a well-recognized global organization in the pharmacovigilance space, a Key Opinion Leader in the pharmaceutical industry’s regulatory discipline of pharmacovigilance and last but not the least; a Thought Leader propagating the scientific facet of pharmacovigilance as an integral part of Medicine in Practice. Although this award may be seen as a professional accolade of an individual, I wish to dutifully highlight and profusely thank my colleagues at Oviya MedSafe for sharing my passion for pharmacovigilance and for showing equal interest in supporting my non-business interests in pharmacovigilance too, as they do for our client-paid projects. With all humility, I wish to express my heartfelt gratitude to the office-bearers of IMA Coimbatore namely Dr N Mahendran (President), Dr M Mariappan (Secretary) and Dr V Rajesh Babu (Finance Secretary) for choosing to recognize me with this prestigious award. The award was presented to me by Prof. E. Balagurusamy (Former Vice Chancellor, Anna University), in the presence of Honourable Judge Thiru. A. Mohamed Jiyaputheen (Tiruppur District) and Prof. M. Padmanabhan (Course Director, State and Central Services Academy & Co-ordinator, Anna IAS Academy, Bharathiar University) on 03-July-2016 at the Doctors Day celebration of IMA Coimbatore.
Moving on to the latter half of the month, I am delighted to mention that the Indian Pharmacovigilance Day 2016 conference chaired by me and sponsored by Oviya MedSafe, was held successfully at Peninsula Grand Hotel, Mumbai on 29-July-2016. Organized for the first time in India by Italy-based EasyB Srl renowned for their ‘Pharmacovigilance Day‘ series of conferences they conduct across Europe, the event was locally coordinated in India by VHEO Ventures, an event management firm. The conference began with the video welcome address of EasyB’s Managing Director Mr Enrico Pedroni and brought out various perspectives of Indian Pharmacovigilance from the constellation of extremely knowledgeable speakers and panellists, whom I wish to sincerely thank from the bottom of my heart, for making this conference a grand success with their active involvement. A detailed post-event note was published by Express Pharma, a media partner of the conference. It was a privilege that senior journalist and Editor of Express Pharma Ms Viveka Roychowdhury personally attended the conference, among many other media professionals. With houseful attendance, the event had delegates from industry, academia and the student community. The complete set of 128 photographs clicked at the conference has been made available for public viewing and/or downloading.
During the conference and subsequent to it, I have been able to feel and realize the immense respect that the name Oviya MedSafe has earned for itself in the minds of pharmacovigilance professionals. On introspection, I can only relate it to the relentless hard work, perpetual capability-building and cross-functional intelligence development that all of us at Oviya MedSafe have been doing over the past 52 months. We are proud as a team to state that our clients, especially those that are either currently kick-starting or propelling their pharmacovigilance systems, look up to us not just as a pharmacovigilance service-provider but as a skilled consultant who would do the best for their clients, with the implicit trust a patient would have on their doctor. With our combined solid experience of learning by working with global pharmaceutical companies (both innovators and generic drug-makers), our home-grown out-of-the-box thinking that adapts such learning for application to smaller clients and our impeccable integrity for which we are known in the industry, we at Oviya MedSafe are all set to support any kind of a client with any type of a pharmacovigilance activity and to fulfil any client’s obligations for compliance with the regulations of any market.
We believe we have lots more to achieve in the vastitude and depth of pharmacovigilance in the forthcoming years. We also earnestly hope that you will be a partner in our pursuit of perfection in pharmacovigilance, in future.
Thanking you for your patient reading and looking forward to meeting you through our August 2016 newsletter,
With thanks & regards,
Dr J Vijay Venkatraman
MBBS, F. Diab., MBA, FPIPA (UK)
Managing Director & CEO,
Oviya MedSafe Pvt Ltd,
Oviya MedSafe UK Ltd,